35S P.tAPX or GUS intronNOS T. G 10-90 P.XVET3A Lex A P.ccdB G 10-90 P.XVET3A Lex A P. tAPX or GUS...
-
Upload
merry-harrison -
Category
Documents
-
view
216 -
download
0
Transcript of 35S P.tAPX or GUS intronNOS T. G 10-90 P.XVET3A Lex A P.ccdB G 10-90 P.XVET3A Lex A P. tAPX or GUS...
35S P. tAPX or GUS
tAPX or GUS
intron NOS T.
G10-90 P. XVE T3AT3A Lex A P. ccdB
G10-90 P. XVE T3AT3A Lex A P. tAPX or GUS
tAPX or GUS
intron
Xba I
pGWB80/tAPX (or GUS)
pMDC7
A
B
C
pMDC7/tAPX (or GUS) RNAi
Xba I
Xba I Spe I
Maruta et al., Supplemental Fig. S1. Plasmid construction for estrogen inducible RNAi. To construct the plasmid for estrogen-inducible silencing of tAPX, DNA fragment containing the 3’-untranslational region of tAPX was cloned into the donor vector, pDONR201, and then recloned into the destination vector, pGWB80. An open reading frame of the beta-Glucuronidase (GUS) gene was also cloned into pGWB80 as a control. PCR and in vitro BP and LR recombination reactions were carried out according to the manufacturer’s instructions (Invitrogen). The specific primers with attB1 and attB2 sequences were as follows: attB1-tAPX3’ (5’-AAAAAGCAGGCTGAGGACAGTCATGGACAGTG-3’), attB2-tAPX3’ (5’-AGAAAGCTGGGTTCACCACGTAATTATGTATGTAGGT-3’), attB1-GUS (5’-AAAAAGCAGGCTATGTTACGTCCTGTAGAAAC-3’), and attB2-GUS (5’-AGAAAGCTGGGTTCATTGTTTGCCTCCCTGCT-3’). DNA sequencing was performed using the dideoxy chain terminator method with an automatic DNA sequencer (ABI PRISMTM 310, Applied Biosystems, http://www.appliedbiosystems.com/). The plasmids obtained, pGWB80/tAPX and pGWB80/GUS (A), were digested with a restriction enzyme Xba I, and then blunted by a Mung Bean Nuclease (Takara). The estrogen-inducible expression vector, pMDC7 (B), was also digested with restriction enzymes, Xba I and Spe I, and blunted. The regions of an RNAi construct having an inverted repeat of tAPX and GUS were ligated to the blunted pMDC7.
RNAi-trigger
XVE
tAPX
Actin8
RNAi-trigger
tAPX
Actin8
wild ty
pe
IS-GUS-2
IS-tAPX-2
IS-tAPX-19
wild ty
pe
IS-GUS-2
IS-tAPX-2
IS-tAPX-19A B
C0 12 16 20 24 (h)
tAPX
Actin8
Maruta et al., Supplemental Fig. S2. Association between expression of tAPX and dsRNA in the IS-tAPX-19 plants during treatment with estrogen. (A) IS-GUS-2, IS-tAPX-2, and IS-tAPX-19 plants (T2 generation) were grown under normal light for 17 days. The transcript levels of tAPX and XVE were determined by sem-quantitative RT-PCR. (B) Seventeen-day-old IS-GUS-2, IS-tAPX-2, and IS-tAPX-19 plants were sprayed with a 100 µM estrogen. At 24 h after the estrogen treatment, the expression of tAPX and RNAi-triggers was determined by semi-quantitative RT-PCR. The expression of RNAi-triggers was indicated using a primer set for the intron region of RNAi-triggers (Supplemental Fig. S1C). Primer sequences were as follows; intron-F (5’-GGTGAGATCTTACTTCTCCT-3’), intron-R (5’-CGAAACTATTTCGCCGAATC-3’). (C) Seventeen-day-old IS-tAPX-19 plants were sprayed with a 100 µM estrogen. A time-course analysis of the expression of tAPX and RNAi-triggers was performed.
IS-tAPX-19-23
IS-GUS-2-17
KO-tAPX
wild type
AtbZIP65 hydrolase
ACS7 PDIL1-1
UP
F-box
ANAC074
5
4
3
2
1
0
76543
12
0
10
8
6
4
2
0
3
2
1
0
3
2
1
0
3
2
1
0
15
10
5
0Rel
ativ
e m
RN
A le
vel
Rel
ativ
e m
RN
A le
vel
Rel
ativ
e m
RN
A le
vel
Rel
ativ
e m
RN
A le
vel
Rel
ativ
e m
RN
A le
vel
Rel
ativ
e m
RN
A le
vel
Rel
ativ
e m
RN
A le
vel
**
*
*
*
*
*
*
*
*
*
*
*
*
Maruta et al., Supplemental Fig. S3. The transcript levels of RTS genes in the estrogen-treated IS-tAPX-19-23 or the KO-tAPX plants. (A) Seventeen-day-old IS-GUS-2-17 and IS-tAPX-19-23 plants were sprayed with a 100 µM estrogen, and kept under normal light. At 48 h after the estrogen treatment, the transcript levels of RTS genes (AtbZIP65, ACS7, UP, F-box, hydrolase, PDIL1-1, and ANAC074) were measured by q-PCR. Error bars indicate SD (n = 3). Significant differences: *P < 0.05 vs. the value for IS-GUS-2-17 plants. (B) The transcript levels of RTS genes in 17-day-old wild-type and KO-tAPX plants were measured by q-PCR. Error bars indicate SD (n = 3). Significant differences: *P < 0.05 vs. the value for wild-type plants.
At3g08970 At2g29490 At2g29470 At2g29460 At1g17170 At2g43510 At1g10585At3g53230
At4g37370 At3g49620At4g37990 At2g41380 At4g22530 At3g54150 At1g26420 At1g26380
At3g26830At3g28210At1g57630At4g01870At3g11340At2g43820At1g22400At1g19020
At1g05340 At2g21640At3g09350 At1g13340 At4g39670 At1g62300 At5g13080 At2g32190
Re
lativ
e
mR
NA
leve
lR
ela
tive
m
RN
A le
vel
Re
lativ
e
mR
NA
leve
lR
ela
tive
m
RN
A le
vel
6
4
2
0
6
4
2
0
6
4
2
0
6
4
2
0
IS-tAPX-19-23IS-GUS-2-17
Maruta et al., Supplemental Fig. S4. The transcript levels of general oxidative stress response markers in the estrogen-treated IS-tAPX-19-23 plants. Seventeen-day-old IS-GUS-2-17 and IS-tAPX-19-23 plants were sprayed with a 100 µM estrogen, and kept under normal light. At 48 h after the estrogen treatment, the transcript levels of “general oxidative stress response markers” were measured by q-PCR. Error bars indicate SD (n = 3).
Maruta et al., Supplemental Fig. S5. Effect of lack of tAPX on cold acclimation under LL. Seventeen-day-old IS-GUS-2-17 and IS-tAPX-19-23 plants were sprayed with a 100 µM estrogen solution or water (mock), and transferred to cold stress conditions (10 µmol photons m -2 s-1, 4°C) for 2 weeks. The treatment with estrogen was performed every 3 days in order to maintain the tAPX silencing. At 14 days after cold stress, the IS-GUS-2-17 and IS-tAPX-19-23 plants were photographed. The same results were obtained in three independent experiments.
EstrogenTreatment
Mock
IS-tAPX-19-23IS-GUS-2-17
KO-tAPXwild typeB
ACOR15BCOR6.6
COR414-TM1
COR414-TM2
Re
lativ
e m
RN
A le
vel
1.5
0.5
1.0
0
KO-tAPXwild type
**
Fv/
Fm
0.6
0.4
0.2
0
B C
Maruta et al., Supplemental Fig. S6. Effect of lack of tAPX on cold acclimation. (A) The wild-type and KO-tAPX plants were grown under light for 17 days. The transcript levels of RTS genes (CBF1/DREB1B, CBF2/DREB1C, COR6.6, COR15B, COR414-TM1, and COR414-TM2) were measured by q-PCR. Error bars indicate SD (n = 3). Significant differences: *P < 0.05 vs. the value for wild-type plants. (B) Seventeen-day-old wild-type and KO-tAPX plants were transferred to cold stress conditions (100 µmol photons m-2 s-1, 4°C). At 2 weeks after cold stress, the wild-type and KO-tAPX plants were photographed. (C) Fv/Fm values in the leaves of wild-type and KO-tAPX at 2 weeks after cold stress were measured using a Closed FluorCam 800MF. Error bars indicate SD (n = 3).
CBF1/DREB1B
CBF2DREB1C
ICS2 RLP7 RLP23 RLP34
Re
lativ
e m
RN
A le
vel
1.5
0.5
1.0
0
KO-tAPXwild type
RLP39 RLP41 AtNUDX6NIMIN-3 LCR68 LCR70
Re
lativ
e m
RN
A le
vel
1.5
0.5
1.0
0
*
* ** * *
***
*
TIR domainprotein
TolB-relatedprotein
Maruta et al., Supplemental Fig. S7. Effect of lack of tAPX on the transcript levels of RTS genes involved in disease resistance. The wild-type and KO-tAPX plants were grown under normal light for 17 days. The transcript levels of RTS genes (ICS2, TolB, TIR, RLP7, RLP23, RLP34, RLP39, RLP41, NIMIN3, NUDX6, LCR68, and LCR70) were measured by q-PCR. Error bars indicate SD (n = 3). Significant differences: *P < 0.05 vs. the value for wild-type plants.
1.0
0.8
0.6
0
0.4
0.2
4
3
2
1
0
KO-tAPX
wild type
Fre
e S
A (
µg
g-1 F
W)
Tota
l SA
(µ
g g-1
FW
)
Maruta et al., Supplemental Fig. S8. Effect of lack of tAPX on the levels of SA. The wild-type and KO-tAPX plants were grown under normal light for 17 days. The levels of free and total SA in the wild-type and KO-tAPX plants were measured as described under ‘‘Experimental Procedures.’’
Maruta et al., Supplemental Fig. S9. Effect of tAPX silencing on HL sensitivity. Seventeen-day-old IS-GUS-2-17 and IS-tAPX-19-23 plants were sprayed with a 100 µM estrogen solution or water (mock), and kept under NL. At 48 h after the treatments, IS-GUS-2-17 and IS-tAPX-19-23 plants were exposed to HL (1000 µmol photons m-2 s-1). (A) At 72 h after HL, the IS-GUS-2-17 and IS-tAPX-19-23 plants were photographed. The same results were obtained in three independent experiments. (B) Fv/Fm values in the leaves of IS-GUS-2-17 and IS-tAPX-19-23 were measured using a Closed FluorCam 800MF. Error bars indicate SD (n = 5).
EstrogenTreatment
Mock
IS-tAPX-19-23IS-GUS-2-17A
1.0
0.8
0.6
0.4
0.2
00 24 48 72 (h)
Fv/
Fm
IS-tAPX-19-23
IS-GUS-2-17